The Waning Effect of Postmenopausal Estrogen Therapy on Osteoporosis
- 14 October 1993
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 329 (16) , 1192-1193
- https://doi.org/10.1056/nejm199310143291610
Abstract
Almost all physicians and their patients believe that estrogen treatment can prevent osteoporosis. Evidence from the Framingham Study reported in this issue of the Journal supports this hypothesis1. In women less than 75 years old who had received long-term estrogen therapy, bone mineral density was higher than in women who had never taken estrogen. In women more than 75 years old, however, there was little difference in bone density between women who had taken estrogen and those who had not. How can we reconcile these results with what is known about the effect of estrogen on the risk of . . .Keywords
This publication has 10 references indexed in Scilit:
- The Effect of Postmenopausal Estrogen Therapy on Bone Density in Elderly WomenNew England Journal of Medicine, 1993
- Treatment of Postmenopausal Osteoporosis with Transdermal EstrogenAnnals of Internal Medicine, 1992
- Exercise and Other Factors in the Prevention of Hip FractureEpidemiology, 1991
- 17β-Estradiol and Continuous Norethisterone: A Unique Treatment for Established Osteoporosis in Elderly WomenJournal of Clinical Endocrinology & Metabolism, 1990
- Estrogen-calcium interactions in the postmenopause: a quantitative descriptionBone and Mineral, 1990
- Appendicular bone density and age predict hip fracture in women. The Study of Osteoporotic Fractures Research GroupJAMA, 1990
- Hip Fracture and the Use of Estrogens in Postmenopausal WomenNew England Journal of Medicine, 1987
- Long-Term Estrogen Replacement Therapy Prevents Bone Loss and FracturesAnnals of Internal Medicine, 1985
- Menopausal Estrogen Therapy and Hip FracturesAnnals of Internal Medicine, 1981
- Decreased Risk of Fractures of the Hip and Lower Forearm with Postmenopausal Use of EstrogenNew England Journal of Medicine, 1980